Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Wei W, Zeng H, Zheng R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020;21(7):e342–e349. doi:10.1016/S1470-2045(20)30073-5
   PubMed Web of Science ®Google Scholar
• Chen HY, Deng J, Wang Y, Wu CQ, Li X, Dai HW. Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater. 2020;112:1–13. doi:10.1016/j.actbio.2020.05.028
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124.doi:10.1038/s41573-020-0090-8
   PubMed Web of Science ®Google Scholar
• Su H, Wang Y, Liu S, et al. Emerging transporter-targeted nanoparticulate drug delivery systems. Acta Pharm Sin B. 2019;9(1):49–58. doi:10.1016/j.apsb.2018.10.005
   PubMed Web of Science ®Google Scholar
• Hettiarachchi SD, Zhou Y, Seven E, et al. Nanoparticle-mediated approaches for Alzheimer’s disease pathogenesis, diagnosis, and therapeutics. J Control Release. 2019;314:125–140. doi:10.1016/j.jconrel.2019.10.034
   PubMed Web of Science ®Google Scholar
• Lee SY, Cho HJ. An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy. Drug Deliv. 2018;25(1):738–749. doi:10.1080/10717544.2018.1446476
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Beygi M, Baradaran B, Mokhtarzadeh A, Shahbazi MA. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small. 2021;17(12):e2006484. doi:10.1002/smll.202006484
   PubMed Web of Science ®Google Scholar
• Kim W, Ly NK, He Y, Li Y, Yuan Z, Yeo, Y. Protein corona: friend or foe? Co-opting serum proteins for nanoparticle delivery. Adv Drug Deliv Rev. 2023;192:114635. doi:10.1016/j.addr.2022.114635
   PubMed Web of Science ®Google Scholar
• Valkenburg KC, de Groot AE, Pienta KJ. Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol. 2018;15(6):366–381. doi:10.1038/s41571-018-0007-1
   PubMed Web of Science ®Google Scholar
• Dhas N, García MC, Kudarha R, et al. Advancements in cell membrane camouflaged nanoparticles: a bioinspired platform for cancer therapy. J Control Release. 2022;346:71–97. doi:10.1016/j.jconrel.2022.04.019
   PubMed Web of Science ®Google Scholar
• Muhamad N, Plengsuriyakarn T, Na-Bangchang K. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomed. 2018;13:3921–3935. doi:10.2147/IJN.S165210
   PubMed Web of Science ®Google Scholar
• Ding Z, Chen W, Jiang F, Mo M, Bi Y, Kong F. Synthesis, characterization and in vitro digestion of folate conjugated chitosan-loaded proanthocyanidins nanoparticles. Food Res Int. 2023;163:112141. doi:10.1016/j.foodres.2022.112141
   PubMed Web of Science ®Google Scholar
• Salehiabar M, Ghaffarlou M, Mohammadi A, et al. Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy. J Control Release. 2023;353:850–863. doi:10.1016/j.jconrel.2022.12.004
   PubMed Web of Science ®Google Scholar
• Treuel L, Brandholt S, Maffre P, Wiegele S, Shang L, Nienhaus GU. Impact of protein modification on the protein corona on nanoparticles and nanoparticle-cell interactions. ACS Nano. 2014;8(1):503–513. doi:10.1021/nn405019v
   PubMed Web of Science ®Google Scholar
• Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288–6308. doi:10.1002/anie.200902672
   PubMed Web of Science ®Google Scholar
• Abu Lila AS, Kiwada H, Ishida T. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage. J Control Release. 2013;172(1):38–47. doi:10.1016/j.jconrel.2013.07.026
   PubMed Web of Science ®Google Scholar
• Yoo JW, Irvine DJ, Discher DE, Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov. 2011;10(7):521–535. doi:10.1038/nrd3499
   PubMed Web of Science ®Google Scholar
• Wang X, Xia Z, Wang H, et al. Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis. Theranostics. 2023;13(10):3224–3244. doi:10.7150/thno.81520
   PubMed Web of Science ®Google Scholar
• Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv Mater. 2018;30(23):e1706759. doi:10.1002/adma.201706759
   PubMed Web of Science ®Google Scholar
• Parodi A, Molinaro R, Sushnitha M, et al. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. Biomaterials. 2017;147:155–168. doi:10.1016/j.biomaterials.2017.09.020
   PubMed Web of Science ®Google Scholar
• Craparo EF, Cabibbo M, Scialabba C, Giammona G, Cavallaro G. Inhalable formulation based on lipid-polymer hybrid nanoparticles for the macrophage targeted delivery of roflumilast. Biomacromolecules. 2022;23(8):3439–3451. doi:10.1021/acs.biomac.2c00576
   PubMed Web of Science ®Google Scholar
• Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine (Lond). 2019;14(1):93–126. doi:10.2217/nnm-2018-0120
   PubMed Web of Science ®Google Scholar
• Zeng S, Tang Q, Xiao M, et al. Cell membrane-coated nanomaterials for cancer therapy. Mater Today Bio. 2023;20:100633. doi:10.1016/j.mtbio.2023.100633
   PubMedGoogle Scholar
• Bogart LK, Pourroy G, Murphy CJ, et al. Nanoparticles for imaging, sensing, and therapeutic intervention. ACS Nano. 2014;8(4):3107–3122. doi:10.1021/nn500962q
   PubMed Web of Science ®Google Scholar
• Li N, Cui W, Cong P, et al. Biomimetic inorganic-organic hybrid nanoparticles from magnesium-substituted amorphous calcium phosphate clusters and polyacrylic acid molecules. Bioact Mater. 2021;6(8):2303–2314. doi:10.1016/j.bioactmat.2021.01.005
   PubMed Web of Science ®Google Scholar
• Furtado D, Björnmalm M, Ayton S, Bush AI, Kempe K, Caruso F. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases. Adv Mater. 2018;30(46):e1801362. doi:10.1002/adma.201801362
   PubMed Web of Science ®Google Scholar
• Aryal S, Hu CM, Fang RH, et al. Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. Nanomedicine (Lond). 2013;8(8):1271–1280. doi:10.2217/nnm.12.153
   PubMed Web of Science ®Google Scholar
• Rao L, Cai B, Bu LL, et al. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano. 2017;11(4):3496–3505. doi:10.1021/acsnano.7b00133
   PubMed Web of Science ®Google Scholar
• Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851. doi:10.1016/j.addr.2021.113851
   PubMed Web of Science ®Google Scholar
• Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078–1094. doi:10.1038/s41578-021-00358-0
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang B, Sun R, et al. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv. 2021;28(1):1397–1418. doi:10.1080/10717544.2021.1938756
   PubMed Web of Science ®Google Scholar
• Afsharzadeh M, Hashemi M, Mokhtarzadeh A, Abnous K, Ramezani M. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Artif Cells Nanomed Biotechnol. 2018;46(6):1095–1110. doi:10.1080/21691401.2017.1376675
   PubMed Web of Science ®Google Scholar
• Neek M, Kim TI, Wang SW. Protein-based nanoparticles in cancer vaccine development. Nanomedicine. 2019;15(1):164–174. doi:10.1016/j.nano.2018.09.004
   PubMed Web of Science ®Google Scholar
• Iqbal H, Yang T, Li T, et al. Serum protein-based nanoparticles for cancer diagnosis and treatment. J Control Release. 2021;329:997–1022. doi:10.1016/j.jconrel.2020.10.030
   PubMed Web of Science ®Google Scholar
• Jia Z, Dai R, Zheng Z, et al. Hollow carbon-based nanosystem for photoacoustic imaging-guided hydrogenothermal therapy in the second near-infrared window. RSC Adv. 2021;11(20):12022–12029. doi:10.1039/D1RA00093D
   PubMed Web of Science ®Google Scholar
• Shang L, Zhou X, Zhang J, Shi Y, Zhong L. Metal nanoparticles for photodynamic therapy: a potential treatment for breast cancer. Molecules. 2021;26(21):6532. doi:10.3390/molecules26216532
   PubMed Web of Science ®Google Scholar
• Yen SK, Padmanabhan P, Selvan ST. Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics. 2013;3(12):986–1003. doi:10.7150/thno.4827
   PubMed Web of Science ®Google Scholar
• Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12):1504–1534. doi:10.1002/adma.201104763
   PubMed Web of Science ®Google Scholar
• Wang S, McGuirk CM, d’Aquino A, Mason JA, Mirkin CA. Metal-organic framework nanoparticles. Adv Mater. 2018;30(37):e1800202. doi:10.1002/adma.201800202
   PubMed Web of Science ®Google Scholar
• Ettlinger R, Lächelt U, Gref R, et al. Toxicity of metal-organic framework nanoparticles: from essential analyses to potential applications. Chem Soc Rev. 2022;51(2):464–484. doi:10.1039/D1CS00918D
   PubMed Web of Science ®Google Scholar
• Wu MX, Yang YW. Metal-Organic Framework (MOF)-based drug/cargo delivery and cancer therapy. Adv Mater. 2017;29(23). doi:10.1002/adma.201606134
   Web of Science ®Google Scholar
• Zhang W, Huang X. Stem cell membrane-camouflaged targeted delivery system in tumor. Mater Today Bio. 2022;16:100377. doi:10.1016/j.mtbio.2022.100377
   PubMedGoogle Scholar
• Yang L, Yang Y, Chen Y, Xu Y, Peng, J. Cell-based drug delivery systems and their in vivo fate. Adv Drug Deliv Rev. 2022;187:114394. doi:10.1016/j.addr.2022.114394
   PubMed Web of Science ®Google Scholar
• Brenner JS, Mitragotri S, Muzykantov VR. Red blood cell hitchhiking: a novel approach for vascular delivery of nanocarriers. Annu Rev Biomed Eng. 2021;23:225–248. doi:10.1146/annurev-bioeng-121219-024239
   PubMed Web of Science ®Google Scholar
• Gravina A, Tediashvili G, Rajalingam R, et al. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. Nat Biotechnol. 2023;41(5):717–727. doi:10.1038/s41587-022-01540-7
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. doi:10.1038/nrc.2016.108
   PubMed Web of Science ®Google Scholar
• Wang H, Alarcón CN, Liu B, et al. Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue. Nat Biomed Eng. 2022;6(7):882–897. doi:10.1038/s41551-021-00815-9
   PubMed Web of Science ®Google Scholar
• Lesch S, Blumenberg V, Stoiber S, et al. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nat Biomed Eng. 2021;5(11):1246–1260. doi:10.1038/s41551-021-00737-6
   PubMed Web of Science ®Google Scholar
• Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: priming the tumor microenvironment. J Control Release. 2015;201:78–89. doi:10.1016/j.jconrel.2014.12.018
   PubMed Web of Science ®Google Scholar
• Goel S, Duda DG, Xu L, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011;91(3):1071–1121. doi:10.1152/physrev.00038.2010
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409–426. doi:10.1007/s10456-017-9562-9
   PubMed Web of Science ®Google Scholar
• Parodi A, Haddix SG, Taghipour N, et al. Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix. ACS Nano. 2014;8(10):9874–9883. doi:10.1021/nn502807n
   PubMed Web of Science ®Google Scholar
• Harper RA, Carpenter GH, Proctor GB, et al. Diminishing biofilm resistance to antimicrobial nanomaterials through electrolyte screening of electrostatic interactions. Colloids Surf B Biointerfaces. 2019;173:392–399. doi:10.1016/j.colsurfb.2018.09.018
   PubMed Web of Science ®Google Scholar
• Wang J, Lu Z, Wientjes MG, Au JL. Delivery of siRNA therapeutics: barriers and carriers. AAPS J. 2010;12(4):492–503. doi:10.1208/s12248-010-9210-4
   PubMed Web of Science ®Google Scholar
• Cuellar M, Cifuentes J, Perez J, et al. Novel BUF2-magnetite nanobioconjugates with cell-penetrating abilities. Int J Nanomed. 2018;13:8087–8094. doi:10.2147/IJN.S188074
   PubMed Web of Science ®Google Scholar
• Gessner I, Neundorf I. Nanoparticles modified with cell-penetrating peptides: conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy. Int J Mol Sci. 2020;21(7):2536. doi:10.3390/ijms21072536
   PubMed Web of Science ®Google Scholar
• Assaraf YG, Brozovic A, Gonçalves AC, et al. The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updates. 2019;46:100645. doi:10.1016/j.drup.2019.100645
   PubMed Web of Science ®Google Scholar
• Hu T, Gong H, Xu J, Huang Y, Wu F, He Z. Nanomedicines for overcoming cancer drug resistance. Pharmaceutics. 2022;14(8):1606. doi:10.3390/pharmaceutics14081606
   PubMed Web of Science ®Google Scholar
• Jiang Y, Chekuri S, Fang RH, Zhang L. Engineering biological interactions on the nanoscale. Curr Opin Biotechnol. 2019;58:1–8. doi:10.1016/j.copbio.2018.10.005
   PubMed Web of Science ®Google Scholar
• Song W, Jia P, Zhang T, et al. Cell membrane-camouflaged inorganic nanoparticles for cancer therapy. J Nanobiotechnology. 2022;20(1):289. doi:10.1186/s12951-022-01475-w
   PubMed Web of Science ®Google Scholar
• Dash P, Piras AM, Dash M. Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy. J Control Release. 2020;327:546–570. doi:10.1016/j.jconrel.2020.09.012
   PubMed Web of Science ®Google Scholar
• Ben-Akiva E, Meyer RA, Yu H, Smith JT, Pardoll DM, Green JJ. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal. Sci Adv. 2020;6(16):eaay9035. doi:10.1126/sciadv.aay9035
   PubMed Web of Science ®Google Scholar
• Jiang Q, Chen M, Yang X, et al. Doxorubicin detoxification in healthy organs improves tolerability to high drug doses for enhanced antitumor therapy. ACS nano. 2023;17(8):7705–7720. doi:10.1021/acsnano.3c00195
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Copp J, Luk BT, Zhang L. A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013;8(5):336–340. doi:10.1038/nnano.2013.54
   PubMed Web of Science ®Google Scholar
• Liu JM, Zhang DD, Fang GZ, Wang S. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery. Biomaterials. 2018;165:39–47. doi:10.1016/j.biomaterials.2018.02.042
   PubMed Web of Science ®Google Scholar
• Liu W, Ruan M, Wang Y, et al. Light-triggered biomimetic nanoerythrocyte for tumor-targeted lung metastatic combination therapy of malignant melanoma. Small. 2018;14(38):e1801754. doi:10.1002/smll.201801754
   PubMed Web of Science ®Google Scholar
• Guo J, Agola JO, Serda R, et al. Biomimetic rebuilding of multifunctional red blood cells: modular design using functional components. ACS Nano. 2020;14(7):7847–7859. doi:10.1021/acsnano.9b08714
   PubMed Web of Science ®Google Scholar
• Chai Z, Ran D, Lu L, et al. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma. ACS Nano. 2019;13(5):5591–5601.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Liu Y, Guo R, et al. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors. Biomaterials. Biomaterials. 2019;192:292–308. doi:10.1016/j.biomaterials.2018.11.021
   PubMed Web of Science ®Google Scholar
• Feng Q, Li Y, Wang N, et al. A biomimetic nanogenerator of reactive nitrogen species based on battlefield transfer strategy for enhanced immunotherapy. Small. 2020;16(25):e2002138. doi:10.1002/smll.202002138
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Z, Zhang Y, et al. Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy. ACS nano. 2018;12(10):10201–10211. doi:10.1021/acsnano.8b05200
   PubMed Web of Science ®Google Scholar
• Song X, Qian R, Li T, et al. Imaging-guided biomimetic M1 macrophage membrane-camouflaged magnetic nanorobots for photothermal immunotargeting cancer therapy. ACS Appl Mater Interfaces. 2022;14(51):56548–56559. doi:10.1021/acsami.2c16457
   PubMed Web of Science ®Google Scholar
• Jain N, Shahrukh S, Famta P, et al. Immune cell-camouflaged surface-engineered nanotherapeutics for cancer management. Acta Biomater. 2023;155:57–79. doi:10.1016/j.actbio.2022.11.001
   PubMed Web of Science ®Google Scholar
• Chen Y, Qin D, Zou J, et al. Living leukocyte-based drug delivery systems. Adv Mater. 2022;35(17):e2207787. doi:10.1002/adma.202207787
   Web of Science ®Google Scholar
• Glassman PM, Hood ED, Ferguson LT, et al. Red blood cells: the metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers. Adv Drug Deliv Rev. 2021;178:113992. doi:10.1016/j.addr.2021.113992
   PubMed Web of Science ®Google Scholar
• Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 2011;108(27):10980–10985. doi:10.1073/pnas.1106634108
   PubMed Web of Science ®Google Scholar
• Xia Q, Zhang Y, Li Z, Hou X, Feng N. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B. 2019;9(4):675–689. doi:10.1016/j.apsb.2019.01.011
   PubMed Web of Science ®Google Scholar
• Rao L, Bu LL, Xu JH, et al. Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance. Small. 2015;11(46):6225–6236. doi:10.1002/smll.201502388
   PubMed Web of Science ®Google Scholar
• Luk BT, Fang RH, Hu CM, et al. Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics. 2016;6(7):1004–1011. doi:10.7150/thno.14471
   PubMed Web of Science ®Google Scholar
• Zhai Y, Ran W, Su J, et al. Traceable bioinspired nanoparticle for the treatment of metastatic breast cancer via NIR-trigged intracellular delivery of methylene blue and cisplatin. Adv Mater. 2018;30(34):e1802378. doi:10.1002/adma.201802378
   Web of Science ®Google Scholar
• Gao M, Liang C, Song X, et al. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy. Adv Mater. 2017;29(35). doi:10.1002/adma.201701429
   Web of Science ®Google Scholar
• Yang X, Yang Y, Gao F, Wei JJ, Qian CG, Sun MJ. Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors. Nano Lett. 2019;19(7):4334–4342. doi:10.1021/acs.nanolett.9b00934
   PubMed Web of Science ®Google Scholar
• Liang L, Cen H, Huang J, et al. The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy. Mol Cancer. 2022;21(1):186. doi:10.1186/s12943-022-01651-4
   PubMed Web of Science ®Google Scholar
• Miao Y, Yang Y, Guo L, et al. Cell membrane-camouflaged nanocarriers with biomimetic deformability of erythrocytes for ultralong circulation and enhanced cancer therapy. ACS Nano. 2022;16(4):6527–6540. doi:10.1021/acsnano.2c00893
   PubMed Web of Science ®Google Scholar
• Xu M, Chang Y, Zhu G, Zhu X, Song X, Li J. Transforming cold tumors into hot ones with a metal-organic framework-based biomimetic nanosystem for enhanced immunotherapy. ACS Appl Mater Interfaces. 2023;15(14):17470–17484. doi:10.1021/acsami.2c21005
   PubMed Web of Science ®Google Scholar
• Xu J, Chen T, Sun T, Yu C, Yan D, Zhu L. Erythrocyte membrane camouflaged siRNA/chemodrug nanoassemblies for cancer combination therapy. Biomater Sci. 2022;10(22):6601–6613. doi:10.1039/D2BM01478E
   PubMed Web of Science ®Google Scholar
• Li JQ, Zhao RX, Yang FM, Qi XT, Ye PK, Xie M. An erythrocyte membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of breast cancer. J Mater Chem B. 2022;10(12):2047–2056. doi:10.1039/D1TB02522H
   PubMed Web of Science ®Google Scholar
• Song Q, Yin Y, Shang L, et al. Tumor microenvironment responsive nanogel for the combinatorial antitumor effect of chemotherapy and immunotherapy. nano Lett. 2017;17(10):6366–6375. doi:10.1021/acs.nanolett.7b03186
   PubMed Web of Science ®Google Scholar
• Daniyal M, Jian Y, Xiao F, et al. Development of a nanodrug-delivery system camouflaged by erythrocyte membranes for the chemo/phototherapy of cancer. Nanomedicine. 2020;15(7):691–709. doi:10.2217/nnm-2019-0454
   PubMed Web of Science ®Google Scholar
• Pihl J, Clausen TM, Zhou J, et al. Malaria biomimetic for tumor targeted drug delivery. acs Nano. 2023;17(14):13500–13509. doi:10.1021/acsnano.3c01910
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian H, Huang J, et al. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int J Nanomed. 2018;13:4961–4975. doi:10.2147/IJN.S170148
   PubMed Web of Science ®Google Scholar
• Gao X, Li S, Ding F, et al. A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy. Adv Mater. 2021;33(9):e2006116. doi:10.1002/adma.202006116
   PubMed Web of Science ®Google Scholar
• Wang T, Luo Y, Lv H, Wang J, Zhang Y, Pei R. Aptamer-based erythrocyte-derived mimic vesicles loaded with siRNA and doxorubicin for the targeted treatment of multidrug-resistant tumors. ACS Appl Mater Interfaces. 2019;11(49):45455–45466. doi:10.1021/acsami.9b16637
   PubMed Web of Science ®Google Scholar
• Zhao Z, Kim J, Suja VC, et al. Red blood cell anchoring enables targeted transduction and re-administration of AAV-mediated gene therapy. Adv Sci. 2022;9(24):e2201293. doi:10.1002/advs.202201293
   Web of Science ®Google Scholar
• Castro F, Martins C, Silveira MJ, Moura RP, Pereira CL, Sarmento B. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments. Adv Drug Deliv Rev. 2021;170:312–339. doi:10.1016/j.addr.2020.09.001
   PubMed Web of Science ®Google Scholar
• Paul DS, Bergmeier W. Novel mouse model for studying hemostatic function of human platelets. Arterioscler Thromb Vasc Biol. 2020;40(8):1891–1904. doi:10.1161/atvbaha.120.314304
   PubMed Web of Science ®Google Scholar
• Li S, Li L, Lin X, Chen C, Luo C, Huang Y. Targeted inhibition of tumor inflammation and tumor-platelet crosstalk by nanoparticle-mediated drug delivery mitigates cancer metastasis. ACS Nano. 2022;16(1):50–67. doi:10.1021/acsnano.1c06022
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Wang KC, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118–121. doi:10.1038/nature15373
   PubMed Web of Science ®Google Scholar
• Jiang Q, Wang K, Zhang X, et al. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy. Small. 2020;16(22):e2001704. doi:10.1002/smll.202001704
   PubMed Web of Science ®Google Scholar
• Li B, Chu T, Wei J, et al. Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment. Nano Lett. 2021;21(6):2588–2595. doi:10.1021/acs.nanolett.1c00168
   PubMed Web of Science ®Google Scholar
• Zhuang J, Gong H, Zhou J, et al. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles. Sci Adv. 2020;6(13):eaaz6108. doi:10.1126/sciadv.aaz6108
   PubMed Web of Science ®Google Scholar
• Wang H, Wu C, Tong X, Chen S. A biomimetic metal-organic framework nanosystem modulates immunosuppressive tumor microenvironment metabolism to amplify immunotherapy. J Control Release. 2023;353:727–737. doi:10.1016/j.jconrel.2022.11.054
   PubMed Web of Science ®Google Scholar
• Ning S, Lyu M, Zhu D, et al. Type-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge. ACS Nano. 2023;17(11):10206–10217. doi:10.1021/acsnano.3c00326
   PubMed Web of Science ®Google Scholar
• Zhang K, Ma Z, Li S, et al. Platelet-covered nanocarriers for targeted delivery of hirudin to eliminate thrombotic complication in tumor therapy. ACS Nano. 2022;16(11):18483–18496. doi:10.1021/acsnano.2c06666
   PubMed Web of Science ®Google Scholar
• Zou J, He J, Wang X, et al. Glycoprotein Ib-regulated micro platelet ghost for biosafe distribution and photothermal oncotherapy. J Control Release. 2022;351:341–360. doi:10.1016/j.jconrel.2022.09.036
   PubMed Web of Science ®Google Scholar
• Bahmani B, Gong H, Luk BT, et al. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors. Nature Commun. 2021;12(1):1999. doi:10.1038/s41467-021-22311-z
   PubMed Web of Science ®Google Scholar
• Pei W, Huang B, Chen S, Wang L, Xu Y, Niu C. Platelet-mimicking drug delivery nanoparticles for enhanced chemo-photothermal therapy of breast cancer. Int J Nanomed. 2020;15:10151–10167. doi:10.2147/IJN.S285952
   PubMed Web of Science ®Google Scholar
• Liu G, Zhao X, Zhang Y, et al. Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity. Adv Mater. 2019;31(32):e1900795. doi:10.1002/adma.201900795
   PubMed Web of Science ®Google Scholar
• Li W, Li F, Li T, et al. Self-actuated biomimetic nanocomposites for photothermal therapy and PD-L1 immunosuppression. Front Chem. 2023;11:1167586. doi:10.3389/fchem.2023.1167586
   PubMed Web of Science ®Google Scholar
• Zhou M, Lai W, Li G, et al. Platelet membrane-coated and VAR2CSA malaria protein-functionalized nanoparticles for targeted treatment of primary and metastatic cancer. ACS Appl Mater Interfaces. 2021;13(22):25635–25648. doi:10.1021/acsami.1c02581
   PubMed Web of Science ®Google Scholar
• Han X, Chen J, Chu J, et al. Platelets as platforms for inhibition of tumor recurrence post-physical therapy by delivery of anti-PD-L1 checkpoint antibody. J Control Release. 2019;304:233–241. doi:10.1016/j.jconrel.2019.05.008
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Luk BT, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14(4):2181–8. doi:10.1021/nl500618u
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao P, Luo Z, et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano. 2016;10(11):10049–10057. doi:10.1021/acsnano.6b04695
   PubMed Web of Science ®Google Scholar
• Xu B, Zeng F, Deng J, et al. A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy. Bioact Mater. 2023;27:337–347. doi:10.1016/j.bioactmat
   PubMed Web of Science ®Google Scholar
• Zhao P, Qiu L, Zhou S, Li L, Qian Z, Zhang H. Cancer cell membrane camouflaged mesoporous silica nanoparticles combined with immune checkpoint blockade for regulating tumor microenvironment and enhancing antitumor therapy. Int J Nanomed. 2021;16:2107–2121. doi:10.2147/IJN.S295565
   PubMed Web of Science ®Google Scholar
• Zheng D, Zhou J, Qian L, et al. Biomimetic nanoparticles drive the mechanism understanding of shear-wave elasticity stiffness in triple negative breast cancers to predict clinical treatment. Bioact Mater. 2023;22:567–587. doi:10.1016/j.bioactmat.2022.10.025
   PubMed Web of Science ®Google Scholar
• Li S, Dong S, Wu J, et al. Surgically derived cancer cell membrane-coated R837-loaded Poly(2-Oxazoline) nanoparticles for prostate cancer immunotherapy. ACS Appl Mater Interfaces. 2023;15(6):7878–7886. doi:10.1021/acsami.2c22363
   PubMedGoogle Scholar
• Yang C, He Y, Chen F, Zhang F, Shao D, Wang Z. Leveraging β-adrenergic receptor signaling blockade for improved cancer immunotherapy through biomimetic nanovaccine. Small. 2023;19(14):e2207029. doi:10.1002/smll.202207029
   PubMed Web of Science ®Google Scholar
• Shen J, Karges J, Xiong K, Chen Y, Ji L, Chao H. Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy. Biomaterials. 2021;275:120979. doi:10.1016/j.biomaterials.2021.120979
   PubMed Web of Science ®Google Scholar
• Zhang F, Hu Q, Li B, et al. A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors. J Control Release. 2023;354:835–850. doi:10.1016/j.jconrel.2023.01.007
   PubMed Web of Science ®Google Scholar
• Nica V, Marino A, Pucci C, et al. Cell-membrane-coated and cell-penetrating peptide-conjugated trimagnetic nanoparticles for targeted magnetic hyperthermia of prostate cancer cells. ACS Appl Mater Interfaces. 2023;15(25):30008–30028. doi:10.1021/acsami.3c07248
   PubMed Web of Science ®Google Scholar
• Li Z, Cai H, Li Z, et al. A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody. Bioact Mater. 2022;21:299–312. doi:10.1016/j.bioactmat.2022.08.028
   PubMed Web of Science ®Google Scholar
• Jin F, Qi J, Liu D, et al. Cancer-cell-biomimetic upconversion nanoparticles combining chemo-photodynamic therapy and cd73 blockade for metastatic triple-negative breast cancer. J Control Release. 2021;337:90–104. Doi:10.1016/j.jconrel.2021.07.021
   PubMed Web of Science ®Google Scholar
• Li SY, Cheng H, Xie BR, et al. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy. ACS Nano. 2017;11(7):7006–7018. doi:10.1021/acsnano.7b02533
   PubMed Web of Science ®Google Scholar
• Xie W, Deng WW, Zan M, et al. Cancer cell membrane camouflaged nanoparticles to realize starvation therapy together with checkpoint blockades for enhancing cancer therapy. ACS Nano. 2019;13(3):2849–2857. doi:10.1021/acsnano.8b03788
   PubMed Web of Science ®Google Scholar
• Yang R, Xu J, Xu L, et al. Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination. ACS Nano. 2018;12(6):5121–5129. doi:10.1021/acsnano.7b09041
   PubMed Web of Science ®Google Scholar
• Meng X, Wang J, Zhou J, et al. Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis. Acta Biomater. 2021;127:266–275. doi:10.1016/j.actbio.2021.03.056
   PubMed Web of Science ®Google Scholar
• Go S, Jung M, Lee S, et al. A personalized cancer nanovaccine that enhances T-cell responses and efficacy through dual interactions with dendritic cells and T cells. Adv Mater. 2023;35(49):e2303979. doi:10.1002/adma.202303979
   PubMedGoogle Scholar
• Li B, Yang T, Liu J, et al. Genetically engineered PD-1 displaying nanovesicles for synergistic checkpoint blockades and chemo-metabolic therapy against non-small cell lung cancer. Acta Biomater. 2023;161:184–200. doi:10.1016/j.actbio.2023.03.002
   PubMed Web of Science ®Google Scholar
• Qi S, Zhang H, Zhang X, et al. Supramolecular engineering of cell membrane vesicles for cancer immunotherapy. Sci Bull. 2022;67(18):1898–1909. doi:10.1016/j.scib.2022.08.030
   PubMed Web of Science ®Google Scholar
• Li Y, Ke J, Jia H, et al. Cancer cell membrane coated PLGA nanoparticles as biomimetic drug delivery system for improved cancer therapy. Colloids Surf B Biointerfaces. 2023;222:113131. doi:10.1016/j.colsurfb.2023.113131
   PubMed Web of Science ®Google Scholar
• Fan L, Wei A, Gao Z, Mu X. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy. Biomed Pharmacother. 2023;161:114451. doi:10.1016/j.biopha.2023.114451
   PubMed Web of Science ®Google Scholar
• Khosravi N, Pishavar E, Baradaran B, Oroojalian F, Mokhtarzadeh A. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: a promising biomimetic nanoplatforms for cancer theranostics. J Control Release. 2022;348:706–722. doi:10.1016/j.jconrel.2022.06.026
   PubMed Web of Science ®Google Scholar
• Gu X, Gao Y, Wang P, et al. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis. J Control Release. 2021;333:374–390. doi:10.1016/j.jconrel.2021.03.039
   PubMed Web of Science ®Google Scholar
• Hoang DM, Pham PT,Bach TQ et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272. doi:10.1038/s41392-022-01134-4
   PubMed Web of Science ®Google Scholar
• Suryaprakash S, Lao YH, Cho HY, et al. Engineered mesenchymal stem cell/nanomedicine spheroid as an active drug delivery platform for combinational glioblastoma therapy. Nano Lett. 2019;19(3):1701–1705. doi:10.1021/acs.nanolett.8b04697
   PubMed Web of Science ®Google Scholar
• Yang N, Ding Y, Zhang Y, et al. Surface functionalization of polymeric nanoparticles with umbilical cord-derived mesenchymal stem cell membrane for tumor-targeted therapy. ACS Appl Mater Interfaces. 2018;10(27):22963–22973. doi:10.1021/acsami.8b05363
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang F, Liu T, et al. Polydopamine nanoparticles camouflaged by stem cell membranes for synergistic chemo-photothermal therapy of malignant bone tumors. Int J Nanomed. 2020;15:10183–10197. doi:10.2147/IJN.S282931
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Wu Z, Lin X, He Q. Stem-cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy. Acs Appl Mater Interfaces. 2016;8(50):34252–34260. doi:10.1021/acsami.6b12865
   PubMed Web of Science ®Google Scholar
• Mu X, Li J, Yan S, et al. siRNA delivery with stem cell membrane-coated magnetic nanoparticles for imaging-guided photothermal therapy and gene therapy. ACS Biomater Sci Eng. 2018;4(11):3895–3905. doi:10.1021/acsbiomaterials.8b00858
   PubMed Web of Science ®Google Scholar
• Ho TC, Kim HS, Chen Y, et al. Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy. Sci Adv. 2021;7(21):eabg3217. doi:10.1126/sciadv.abg3217
   Web of Science ®Google Scholar
• Tian W, Lu J, Jiao D. Stem cell membrane vesicle–coated nanoparticles for efficient tumor‐targeted therapy of orthotopic breast cancer. Polym Adv Technol. 2019;30(4):1051–1060. doi:10.1002/pat.4538
   Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado-Sánchez B, Lin X, Wu Z, He Q. Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small. 2016;12(30):4056–4062. Doi:10.1002/smll.201600624
   PubMed Web of Science ®Google Scholar
• Zhou D, Chen Y, Bu W, et al. Modification of metal-organic framework nanoparticles using dental pulp mesenchymal stem cell membranes to target oral squamous cell carcinoma. J Colloid Interface Sci. 2021;601:650–660. doi:10.1016/j.jcis.2021.05.126
   PubMed Web of Science ®Google Scholar
• Xie L, Zhang C, Liu M, et al. Nucleus-targeting manganese dioxide nanoparticles coated with the human umbilical cord mesenchymal stem cell membrane for cancer cell therapy. ACS Appl Mater Interfaces. 2023;15(8):10541–10553. doi:10.1021/acsami.3c01176
   PubMedGoogle Scholar
• Zhang J, Han M, Zhang J, et al. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism. Int J Pharm. 2023;640:123025. doi:10.1016/j.ijpharm.2023.123025
   PubMedGoogle Scholar
• Taghavi S, Tabasi H, Zahiri M, et al. Surface engineering of hollow gold nanoparticle with mesenchymal stem cell membrane and muc-1 aptamer for targeted theranostic application against metastatic breast cancer. Eur J Pharm Biopharm. 2023;187:76–86. doi:10.1016/j.ejpb.2023.04.014
   PubMed Web of Science ®Google Scholar
• Li YS, Wu HH, Jiang XC, et al. Active stealth and self-positioning biomimetic vehicles achieved effective antitumor therapy. J Control Release. 2021;335:515–526. doi:10.1016/j.jconrel.2021.05.031
   PubMed Web of Science ®Google Scholar
• Chang Y, Cai X, Syahirah R, et al. CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nature Commun. 2023;14(1):2266. doi:10.1038/s41467-023-37872-4
   PubMed Web of Science ®Google Scholar
• Lança T, Silva-Santos B. The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy. Oncoimmunology. 2012;1(5):717–725. doi:10.4161/onci.20068
   PubMed Web of Science ®Google Scholar
• Liu Y, Li H, Qiu Y-L, Li K-S, Lu Y, Wang W. Nanoscale biomimetic nano system for the co-delivery of SNS032 and tumor necrosis factor related apoptosis inducing ligand to enhance therapeutic efficacy in oral squamous cell carcinoma cell line SCC25. Materials Express. 2021;11(8):1321–1330. doi:10.1166/mex.2021.2055
   Web of Science ®Google Scholar
• Kloosterman DJ, Akkari L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell. 2023;186(8):1627–1651. doi:10.1016/j.cell.2023.02.020
   PubMed Web of Science ®Google Scholar
• Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15(1):123–147. doi:10.1146/annurev-pathmechdis-012418-012718
   PubMed Web of Science ®Google Scholar
• Naitik J, Srinivasarao DA, Famta P, et al. The portrayal of macrophages as tools and targets: a paradigm shift in cancer management. Life Sci. 2023;316:121399. doi:10.1016/j.lfs.2023.121399
   PubMedGoogle Scholar
• Choo YW, Kang M, Kim HY, et al. M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors. ACS Nano. 2018;12(9):8977–8993. doi:10.1021/acsnano.8b02446
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cai K, Li C, et al. Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy. Nano Lett. 2018;18(3):1908–1915. doi:10.1021/acs.nanolett.7b05263
   PubMed Web of Science ®Google Scholar
• Xu L, Wang X, Wang R, Liu S, Xu M. Engineered macrophages: a safe-by-design approach for the tumor targeting delivery of sub-5 nm gold nanoparticles. Small. 2023;19(1):e2205474. doi:10.1002/smll.202205474
   PubMed Web of Science ®Google Scholar
• Liang B, Deng T, Li J, Ouyang X, Na W, Deng D. Biomimetic theranostic strategy for anti-metastasis therapy of breast cancer via the macrophage membrane camouflaged superparticles. Mater Sci Eng C Mater Biol Appl. 2020;115:111097. doi:10.1016/j.msec.2020.111097
   PubMed Web of Science ®Google Scholar
• Lai J, Deng G, Sun Z, et al. Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing blood-brain barrier. Biomaterials. 2019;211:48–56. doi:10.1016/j.biomaterials.2019.04.026
   PubMed Web of Science ®Google Scholar
• Wang D, Gao C, Zhou C, Lin Z, He Q. Leukocyte membrane-coated liquid metal nanoswimmers for actively targeted delivery and synergistic chemophotothermal therapy. Research (Wash D C). 2020;2020:3676954. doi:10.34133/2020/3676954
   PubMedGoogle Scholar
• Ding J, Lu J, Zhang Q, et al. Camouflage nanoparticles enable in situ bioluminescence-driven optogenetic therapy of retinoblastoma. ACS Nano. 2023;17(8):7750–7764. doi:10.1021/acsnano.3c00470
   PubMed Web of Science ®Google Scholar
• Chen C, Song M, Du Y, et al. Tumor-associated-macrophage-membrane-coated nanoparticles for improved photodynamic immunotherapy. Nano Lett. 2021;21(13):5522–5531. doi:10.1021/acs.nanolett.1c00818
   PubMed Web of Science ®Google Scholar
• Wen X, Xiong X, Yang G, et al. A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy. J Control Release. 2023;353:535–548. doi:10.1016/j.jconrel.2022.12.001
   PubMed Web of Science ®Google Scholar
• Li Y, Yan T, Chang W, Cao C, Deng D. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer. BIOMATER SCI. 2019;7(9):3652–3661. doi:10.1039/c9bm00630c
   PubMed Web of Science ®Google Scholar
• Zhang F, Li F, Lu GH, et al. Engineering magnetosomes for ferroptosis/immunomodulation synergism in cancer. ACS Nano. 2019;13(5):5662–5673. doi:10.1021/acsnano.9b00892
   PubMed Web of Science ®Google Scholar
• Gungabeesoon J, Gort-Freitas NA, Kiss M, et al. A neutrophil response linked to tumor control in immunotherapy. Cell. 2023;186(7):1448–1464.e1420. doi:10.1016/j.cell.2023.02.032
   PubMed Web of Science ®Google Scholar
• Siwicki M, Pittet MJ. Versatile neutrophil functions in cancer. Semin Immunol. 2021;57:101538. doi:10.1016/j.smim.2021.101538
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Kersten K, Doornebal CW, et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345–348. doi:10.1038/nature14282
   PubMed Web of Science ®Google Scholar
• Kang T, Zhu Q, Wei D, et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano. 2017;11(2):1397–1411. doi:10.1021/acsnano.6b06477
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang L, Wu W, et al. Artificial super neutrophils for inflammation targeting and HClO generation against tumors and infections. Adv Mater. 2019;31(19):e1901179. doi:10.1002/adma.201901179
   PubMed Web of Science ®Google Scholar
• Cao X, Hu Y, Luo S, et al. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharm Sin B. 2019;9(3):575–589. doi:10.1016/j.apsb.2018.12.009
   PubMed Web of Science ®Google Scholar
• Xue J, Zhao Z, Zhang L, et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol. 2017;12(7):692–700. doi:10.1038/nnano.2017.54
   PubMed Web of Science ®Google Scholar
• Xia C, Bai W, Deng T, et al. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche. Acta Biomater. 2023;158:708–724. doi:10.1016/j.actbio.2023.01.009
   PubMed Web of Science ®Google Scholar
• Yu X, Xing G, Sheng S, et al. Neutrophil camouflaged stealth nanovehicle for photothermal-induced tumor immunotherapy by triggering pyroptosis. Adv Sci. 2023;10(15):e2207456. doi:10.1002/advs.202207456
   Web of Science ®Google Scholar
• Lancaster JN, Thyagarajan HM, Srinivasan J, Li Y, Hu Z, Ehrlich LIR. Live-cell imaging reveals the relative contributions of antigen-presenting cell subsets to thymic central tolerance. Nature Commun. 2019;10(1):2220. doi:10.1038/s41467-019-09727-4
   PubMedGoogle Scholar
• Kurotaki D, Kawase W, Sasaki H, et al. Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice. Blood. 2019;133(17):1803–1813. doi:10.1182/blood-2018-06-857789
   PubMed Web of Science ®Google Scholar
• Carreno BM, Magrini V, Becker-Hapak M, et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015;348(6236):803–808. doi:10.1126/science.aaa3828
   PubMed Web of Science ®Google Scholar
• Liang X, Cheng H, Liu C, Liu G. Antigen self-presenting nanovaccine for cancer immunotherapy. Sci Bull. 2022;67(16):1611–1613. doi:10.1016/j.scib.2022.07.018
   PubMed Web of Science ®Google Scholar
• Cheng S, Xu C, Jin Y, et al. Artificial mini dendritic cells boost T cell-based immunotherapy for ovarian cancer. Adv Sci (Weinh). 2020;7(7):1903301. doi:10.1002/advs.201903301
   PubMedGoogle Scholar
• Liu C, Liu X, Xiang X, et al. A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy. Nature Nanotechnol. 2022;17(5):531–540. doi:10.1038/s41565-022-01098-0
   PubMed Web of Science ®Google Scholar
• Ma X, Kuang L, Yin Y, et al. Tumor-antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma. ACS Nano. 2022;17(3):2341–2355. doi:10.1021/acsnano.2c09033
   Web of Science ®Google Scholar
• Yang X, Yang T, Liu Q, et al. Biomimetic aggregation‐induced emission nanodots with hitchhiking function for T cell‐mediated cancer targeting and NIR‐II fluorescence‐guided mild‐temperature photothermal therapy. Adv Funct Mater. 2022;32(45):2206346.1–2206346.13. doi:10.1002/adfm.202206346
   Web of Science ®Google Scholar
• Fridman WH, Zitvogel L, Sautès-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14(12):717–734. doi:10.1038/nrclinonc.2017.101
   PubMed Web of Science ®Google Scholar
• Kang M, Hong J, Jung M, et al. T-cell-mimicking nanoparticles for cancer immunotherapy. Adv Mater. 2020;32(39):e2003368. doi:10.1002/adma.202003368
   PubMed Web of Science ®Google Scholar
• Zhang L, Li R, Chen H, et al. Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. Int J Nanomed. 2017;12:2129–2142. doi:10.2147/IJN.S126016
   PubMed Web of Science ®Google Scholar
• Zhai Y, Wang J, Lang T, et al. T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy. Nat Nanotechnol. 2021;16(11):1271–1280. doi:10.1038/s41565-021-00972-7
   PubMed Web of Science ®Google Scholar
• Ma W, Zhu D, Li J, et al. Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. Theranostics. 2020;10(3):1281–1295. doi:10.7150/thno.40291
   PubMed Web of Science ®Google Scholar
• Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev. 2013;12(4):1069–1078. doi:10.1016/j.arr.2013.04.003
   PubMed Web of Science ®Google Scholar
• Baier C, Fino A, Sanchez C, et al. Natural killer cells modulation in hematological malignancies. Front Immunol. 2013;4:459. doi:10.3389/fimmu.2013.00459
   PubMed Web of Science ®Google Scholar
• Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436(7051):709–713. doi:10.1038/nature03847
   PubMed Web of Science ®Google Scholar
• Keener AB. Natural killers: cataloging immune cells for immunotherapy. Nat Med. 2015;21(3):207–208. doi:10.1038/nm0315-207
   PubMed Web of Science ®Google Scholar
• Zheng C, Zhong Q, Song W, et al. Membrane-fusion-mediated multiplex engineering of tumor cell surface glycans for enhanced NK cell therapy. Adv Mater. 2023;35(14):e2206989. doi:10.1002/adma.202206989
   PubMed Web of Science ®Google Scholar
• Pan S, Guan J, Xianyu B, Tan Y, Li T, Xu H. A nanotherapeutic strategy to reverse NK cell exhaustion. Adv Mater. 2023;35(23):e2211370. doi:10.1002/adma.202211370
   PubMed Web of Science ®Google Scholar
• Liu S, Galat V, Galat Y, Lee YKA, Wainwright D, Wu J. NK cell-based cancer immunotherapy: from basic biology to clinical development. J Hematol Oncol. 2021;14(1):7. doi:10.1186/s13045-020-01014-w
   PubMed Web of Science ®Google Scholar
• Deng G, Sun Z, Li S, et al. Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth. ACS Nano. 2018;12(12):12096–12108. doi:10.1021/acsnano.8b05292
   PubMed Web of Science ®Google Scholar
• Du W, Chen C, Sun P, et al. Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy. Nanoscale. 2020;12(5):3317–3329. doi:10.1039/C9NR09835F
   PubMed Web of Science ®Google Scholar
• Pitchaimani A, Nguyen TDT, Aryal S. Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy. Biomaterials. 2018;160:124–137. doi:10.1016/j.biomaterials.2018.01.018
   PubMed Web of Science ®Google Scholar
• Poetsch A, Wolters D. Bacterial membrane proteomics. Proteomics. 2008;8(19):4100–4122. doi:10.1002/pmic.200800273
   PubMed Web of Science ®Google Scholar
• Gao W, Fang RH, Thamphiwatana S, et al. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett. 2015;15(2):1403–1409. doi:10.1021/nl504798g
   PubMed Web of Science ®Google Scholar
• Patel RB, Ye M, Carlson PM, et al. Development of an in situ cancer vaccine via combinational radiation and bacterial-membrane-coated nanoparticles. Adv Mater. 2019;31(43):e1902626. doi:10.1002/adma.201902626
   PubMed Web of Science ®Google Scholar
• Naskar A, Cho H, Lee S, Kim KS. Biomimetic nanoparticles coated with bacterial outer membrane vesicles as a new-generation platform for biomedical applications. Pharmaceutics. 2021;13(11):1887. doi:10.3390/pharmaceutics13111887
   PubMed Web of Science ®Google Scholar
• Gao C, Wang Q, Li J, et al. In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma. Sci Adv. 2022;8(19):eabn1805. doi:10.1126/sciadv.abn1805
   PubMed Web of Science ®Google Scholar
• Chen W, Song Y, Bai S, et al. Cloaking mesoporous polydopamine with bacterial membrane vesicles to amplify local and systemic antitumor immunity. ACS Nano. 2023;17(8):7733–7749. doi:10.1021/acsnano.3c00363
   PubMed Web of Science ®Google Scholar
• Dong L, Huang CY, Johnson EJ, et al. High-throughput simultaneous mRNA profiling using nCounter technology demonstrates that extracellular vesicles contain different mRNA transcripts than their parental prostate cancer cells. Anal Chem. 2021;93(8):3717–3725. doi:10.1021/acs.analchem.0c03185
   PubMed Web of Science ®Google Scholar
• Sartorio MG, Pardue EJ, Feldman MF, Haurat MF. Bacterial outer membrane vesicles: from discovery to applications. Annu Rev Microbiol. 2021;75(1):609–630. doi:10.1146/annurev-micro-052821-031444
   PubMedGoogle Scholar
• Deshmukh SK, Khan MA, Singh S, Singh AP. Extracellular nanovesicles: from intercellular messengers to efficient drug delivery systems. ACS Omega. 2021;6(3):1773–1779. doi:10.1021/acsomega.0c05539
   PubMed Web of Science ®Google Scholar
• Yellon DM, Davidson SM. Exosomes: nanoparticles involved in cardioprotection? Circ Res. 2014;114(2):325–332. doi:10.1161/CIRCRESAHA.113.300636
   PubMed Web of Science ®Google Scholar
• Weng Z, Zhang B, Wu C, et al. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol. 2021;14(1):136. doi:10.1186/s13045-021-01141-y
   PubMed Web of Science ®Google Scholar
• Xiao Q, Zhao W, Wu C, et al. Lemon-derived extracellular vesicles nanodrugs enable to efficiently overcome cancer multidrug resistance by endocytosis-triggered energy dissipation and energy production reduction. Adv Sci. 2022;9(20):e2105274. doi:10.1002/advs.202105274
   Web of Science ®Google Scholar
• Lim KM, Han JH, Lee Y, et al. Rapid production method with increased yield of high-purity extracellular vesicles obtained using extended mitochondrial targeting domain peptide. J Extracell Vesicles. 2022;11(10):e12274. doi:10.1002/jev2.12274
   PubMed Web of Science ®Google Scholar
• Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H. Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis. J Control Release. 2020;318:1–15. doi:10.1016/j.jconrel.2019.12.005
   PubMed Web of Science ®Google Scholar
• Pei W, Li X, Bi R, et al. Exosome membrane-modified M2 macrophages targeted nanomedicine: treatment for allergic asthma. J Control Release. 2021;338:253–267. doi:10.1016/j.jconrel.2021.08.024
   PubMed Web of Science ®Google Scholar
• Zuo L, Nie W, Yu S, et al. Biomimetic nanovesicle with mitochondria-synthesized sonosensitizer and mitophagy inhibition for cancer sono-immunotherapy. Nano Lett. 2023;23(7):3005–3013. doi:10.1021/acs.nanolett.3c00383
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhai Y, Hao Y, et al. Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides. J Extracell Vesicles. 2022;11(8):e12255. doi:10.1002/jev2.12255
   PubMed Web of Science ®Google Scholar
• Hosseini-Giv N, Basas A, Hicks C, El-Omar E, El-Assaad F, Hosseini-Beheshti E. Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer. Front Cell Infect Microbiol. 2022;12:962216. doi:10.3389/fcimb.2022.962216
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang H, Han Y, Hu Y, Geng Z, Su J. Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy. Theranostics. 2022;12(15):6576–6594. doi:10.7150/thno.78034
   PubMed Web of Science ®Google Scholar
• Suri K, D’Souza A, Huang D, Bhavsar A, Amiji M. Bacterial extracellular vesicle applications in cancer immunotherapy. Bioact Mater. 2023;22:551–566. doi:10.1016/j.bioactmat.2022.10.024
   PubMed Web of Science ®Google Scholar
• Lusta KA, Poznyak AV, Litvinova L, Poggio P, Orekhov AN, Melnichenko AA. Involvement of bacterial extracellular membrane nanovesicles in infectious diseases and their application in medicine. Pharmaceutics. 2022;14(12):2597. doi:10.3390/pharmaceutics14122597
   PubMed Web of Science ®Google Scholar
• Lieberman LA. Outer membrane vesicles: a bacterial-derived vaccination system. Front Microbiol. 2022;13:1029146. doi:10.3389/fmicb.2022.1029146
   PubMed Web of Science ®Google Scholar
• Cheng K, Zhao R, Li Y, et al. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via plug-and-display technology. Nature Commun. 2021;12(1):2041. doi:10.1038/s41467-021-22308-8
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang K, Wu Y, et al. Antigen capture and immune modulation by bacterial outer membrane vesicles as in situ vaccine for cancer immunotherapy post-photothermal therapy. Small. 2022;18(14):e2107461. doi:10.1002/smll.202107461
   PubMed Web of Science ®Google Scholar
• Wang S, Gao J, Wang Z. Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(2):e1523. doi:10.1002/wnan.1523
   PubMed Web of Science ®Google Scholar
• Weyant KB, Oloyede A, Pal S, et al. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens. Nat Commun. 2023;14(1):464. doi:10.1038/s41467-023-36101-2
   PubMed Web of Science ®Google Scholar
• Feng B, Wu J, Shen B, Jiang F, Feng J. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures. Cancer Cell Int. 2022;22(1):166. doi:10.1186/s12935-022-02599-7
   PubMed Web of Science ®Google Scholar
• Li H, Wan J. Lipid metabolism in tumor-associated fibroblasts. Adv Exp Med Biol. 2021;1316:117–131. doi:10.1007/978-981-33-6785-2_8
   PubMed Web of Science ®Google Scholar
• Li J, Zhen X, Lyu Y, Jiang Y, Huang J, Pu K. Cell membrane coated semiconducting polymer nanoparticles for enhanced multimodal cancer phototheranostics. ACS Nano. 2018;12(8):8520–8530. doi:10.1021/acsnano.8b04066
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liao Y, Tang Q, Lin J, Huang P. Biomimetic nanoemulsion for synergistic photodynamic-immunotherapy against hypoxic breast tumor. Angew Chem Int Ed Engl. 2021;60(19):10647–10653. doi:10.1002/anie.202015590
   PubMed Web of Science ®Google Scholar
• Niu W, Xiao Q, Wang X, et al. A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy. Nano Lett. 2021;21(3):1484–1492. doi:10.1021/acs.nanolett.0c04753
   PubMed Web of Science ®Google Scholar
• Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20(1):33–48. doi:10.1038/s41571-022-00699-x
   PubMed Web of Science ®Google Scholar
• Dehaini D, Wei X, Fang RH, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29(16). doi:10.1002/adma.201606209
   Web of Science ®Google Scholar
• Wang D, Dong H, Li M, et al. Erythrocyte–cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano. 2018;12(6):5241–5252. doi:10.1021/acsnano.7b08355
   PubMed Web of Science ®Google Scholar
• Rezaei S, de Araújo Júnior RF, da Silva ILG, Schomann T, Eich C, Cruz LJ. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer. Biomater Adv. 2023;151:213456. doi:10.1016/j.bioadv.2023.213456
   PubMedGoogle Scholar
• Xiong J, Wu M, Chen J, et al. Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer. ACS nano. 2021;15(12):19756–19770. doi:10.1021/acsnano.1c07180
   PubMed Web of Science ®Google Scholar
• Sun M, Duan Y, Ma Y, Zhang Q. Cancer cell-erythrocyte hybrid membrane coated gold nanocages for near infrared light-activated photothermal/radio/chemotherapy of breast cancer. Int J Nanomed. 2020;15:6749–6760. doi:10.2147/IJN.S266405
   PubMed Web of Science ®Google Scholar
• Li H, Peng Q, Yang L, et al. High-performance dual combination therapy for cancer treatment with hybrid membrane-camouflaged mesoporous silica gold nanorods. ACS Appl Mater Interfaces. 2020;12(52):57732–57745. doi:10.1021/acsami.0c18287
   PubMed Web of Science ®Google Scholar
• Wu L, Li Q, Deng J, et al. Platelet-tumor cell hybrid membrane-camouflaged nanoparticles for enhancing therapy efficacy in Glioma. Int J Nanomed. 2021;16:8433–8446. doi:10.2147/IJN.S333279
   PubMed Web of Science ®Google Scholar
• Li Z, Yang G, Han L, Wang R, Gong C, Yuan Y. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma. J Nanobiotechnology. 2021;19(1):360. doi:10.1186/s12951-021-01095-w
   PubMed Web of Science ®Google Scholar
• Ma J, Dai L, Yu J, et al. Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials. 2023;295:122026. doi:10.1016/j.biomaterials.2023.122026
   PubMed Web of Science ®Google Scholar
• Rao L, Meng QF, Huang Q, et al. Platelet–leukocyte hybrid membrane‐coated immunomagnetic beads for highly efficient and highly specific isolation of circulating tumor cells. Adv. Funct. Mater. 2018;28(34):1803531.1–1803531.9. doi:10.1002/adfm.201803531
   Web of Science ®Google Scholar
• He H, Guo C, Wang J, et al. Leutusome: a biomimetic nanoplatform integrating plasma membrane components of leukocytes and tumor cells for remarkably enhanced solid tumor homing. Nano Lett. 2018;18(10):6164–6174. doi:10.1021/acs.nanolett.8b01892
   PubMed Web of Science ®Google Scholar
• Gong C, Yu X, You B, et al. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. J Nanobiotechnology. 2020;18(1):92. doi:10.1186/s12951-020-00649-8
   PubMed Web of Science ®Google Scholar
• Liu WL, Zou MZ, Liu T, et al. Expandable immunotherapeutic nanoplatforms engineered from cytomembranes of hybrid cells derived from cancer and dendritic cells. Adv Mater. 2019;31(18):e1900499. doi:10.1002/adma.201900499
   PubMed Web of Science ®Google Scholar
• Hao W, Cui Y, Fan Y, et al. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery. J Nanobiotechnology. 2021;19(1):378. doi:10.1186/s12951-021-01110-0
   PubMed Web of Science ®Google Scholar
• Bu LL, Rao L, Yu GT, et al. Cancer stem cell‐platelet hybrid membrane‐coated magnetic nanoparticles for enhanced photothermal therapy of head and neck squamous cell carcinoma. Adv. Funct. Mater. 2019;29(10):1807733–1807733. doi:10.1002/adfm.201807733
   Web of Science ®Google Scholar
• Yin Y, Tang W, Ma X et al. Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma. Chem Eng J. 2022;433P3:133848,2–11.doi:10.1016/j.cej.2021.133848
   Google Scholar
• Chen Q, Huang G, Wu W, et al. A hybrid eukaryotic-prokaryotic nanoplatform with photothermal modality for enhanced antitumor vaccination. Adv Mater. 2020;32(16):e1908185. doi:10.1002/adma.201908185
   PubMed Web of Science ®Google Scholar
• Wang D, Liu C, You S, et al. Bacterial vesicle-cancer cell hybrid membrane-coated nanoparticles for tumor specific immune activation and photothermal therapy. Acs Appl Mater Interfaces. 2020;12(37):41138–41147. doi:10.1021/acsami.0c13169
   PubMed Web of Science ®Google Scholar
• Zhang W, Gong C, Chen Z, Li M, Li Y, Gao J. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer. J Nanobiotechnology. 2021;19(1):339. doi:10.1186/s12951-021-01085-y
   PubMed Web of Science ®Google Scholar
• Ye H, Wang K, Zhao J, et al. In situ sprayed nanovaccine suppressing exosomal PD-L1 by golgi apparatus disorganization for postsurgical melanoma immunotherapy. ACS Nano. 2023;17(11):10637–10650. doi:10.1021/acsnano.3c01733
   PubMed Web of Science ®Google Scholar
• Zhang J, Wei L, Ma X, et al. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity. Acta Biomater. 2023;166:470–484. doi:10.1016/j.actbio.2023.05.040
   PubMed Web of Science ®Google Scholar
• Ma W, Yang Y, Zhu J, et al. Biomimetic nanoerythrosome-coated aptamer-DNA tetrahedron/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer. Adv Mater. 2022;34(46):e2109609. doi:10.1002/adma.202109609
   PubMed Web of Science ®Google Scholar
• Rao L, Wu L, Liu Z, et al. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. NAT COMMUN. 2020;11(1):4909. doi:10.1038/s41467-020-18626-y
   PubMed Web of Science ®Google Scholar
• Wang W, Liu S, Dai P, et al. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia. J Immunother Cancer. 2021;9(9):e002569. Doi:10.1136/jitc-2021-002569
   PubMed Web of Science ®Google Scholar
• Silva-Pilipich N, Blanco E, Lozano T, et al. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses. Cancer Lett. 2023;561:216139. doi:10.1016/j.canlet.2023.216139
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang Y, Jiang W, et al. Herpesvirus-mimicking DNAzyme-loaded nanoparticles as a mitochondrial DNA stress inducer to activate innate immunity for tumor therapy. Adv Mater. 2022;34(37):e2204585. doi:10.1002/adma.202204585
   PubMed Web of Science ®Google Scholar
• Han S, Wang W, Wang S, et al. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Theranostics. 2021;11(6):2892–2916. doi:10.7150/thno.50928
   PubMed Web of Science ®Google Scholar
• Xue C, Hu S, Gao ZH, et al. Programmably tiling rigidified DNA brick on gold nanoparticle as multi-functional shell for cancer-targeted delivery of siRNAs. Nat Commun. 2021;12(1):2928. doi:10.1038/s41467-021-23250-5
   PubMed Web of Science ®Google Scholar
• Yuan P, Chen X, Li X, et al. Effect of Cell Membrane-cloaked Nanoparticle Elasticity on Nano-Bio Interaction. Small Methods;2023.;7(6):e2201548. doi:10.1002/smtd.202201548
   PubMed Web of Science ®Google Scholar